RESUMO
Contemporary science has become increasingly multi-disciplinary and team-based, resulting in unprecedented growth in biomedical innovation and technology over the last several decades. Collaborative research efforts have enabled investigators to respond to the demands of an increasingly complex 21st century landscape, including pressing scientific challenges such as the COVID-19 pandemic. A major contributing factor to the success of team science is the mobilization of core facilities and shared research resources (SRRs), the scientific instrumentation and expertise that exist within research organizations that enable widespread access to advanced technologies for trainees, faculty, and staff. For over 40 years, SRRs have played a key role in accelerating biomedical research discoveries, yet a national strategy that addresses how to leverage these resources to enhance team science and achieve shared scientific goals is noticeably absent. We believe a national strategy for biomedical SRRs-led by the National Institutes of Health-is crucial to advance key national initiatives, enable long-term research efficiency, and provide a solid foundation for the next generation of scientists.
Assuntos
Pesquisa Biomédica/organização & administração , COVID-19 , Colaboração Intersetorial , National Institutes of Health (U.S.)/organização & administração , Pandemias , SARS-CoV-2 , Academias e Institutos/organização & administração , Mobilidade Ocupacional , Congressos como Assunto , Humanos , Políticas , Avaliação de Programas e Projetos de Saúde , Apoio à Pesquisa como Assunto , Sociedades Científicas/organização & administração , Participação dos Interessados , Estados Unidos , Universidades/organização & administraçãoRESUMO
Universities and research institutions have to assess individuals when making decisions about hiring, promotion and tenure, but there are concerns that such assessments are overly reliant on metrics and proxy measures of research quality that overlook important factors such as academic rigor, data sharing and mentoring. These concerns have led to calls for universities and institutions to reform the methods they use to assess research and researchers. Here we present a new tool called SPACE that has been designed to help universities and institutions implement such reforms. The tool focuses on five core capabilities and can be used by universities and institutions at all stages of reform process.
Assuntos
Sucesso Acadêmico , Academias e Institutos , Docentes , Pesquisadores , Universidades , Academias e Institutos/organização & administração , Academias e Institutos/normas , Mobilidade Ocupacional , Docentes/organização & administração , Docentes/normas , Humanos , Cultura Organizacional , Seleção de Pessoal , Formulação de Políticas , Pesquisadores/organização & administração , Pesquisadores/normasRESUMO
A unique experiment in bringing academic and industrial scientists together to tackle endemic infectious diseases has proved a success. The Tres Cantos Open Lab Foundation, guided and advised by independent experts, funds extended stays of academics at the campus of a pharmaceutical company, where they access the firm's resources in partnership with company scientists. Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has sustained the decade-long evolution of the model, whose distinctive features complement other public-private partnerships with similar goals.
Assuntos
Doenças Transmissíveis/tratamento farmacológico , Desenvolvimento de Medicamentos/organização & administração , Indústria Farmacêutica/organização & administração , Doenças Endêmicas , Academias e Institutos/organização & administração , Humanos , Parcerias Público-PrivadasRESUMO
PURPOSE: To review home- and office-based vergence and accommodative therapies for treatment of convergence insufficiency (CI) in children and young adults up to 35 years of age. METHODS: Literature searches were conducted through October 2020 in the PubMed database for English-language studies. The combined searches yielded 359 abstracts, of which 37 were reviewed in full text. Twelve of these were considered appropriate for inclusion in this assessment and assigned a level of evidence rating by the panel methodologist. RESULTS: Of the 12 studies included in this assessment, 8 were graded as level I evidence, 2 were graded as level II evidence, and 2 were graded as level III evidence. Two of the level I studies included older teenagers and young adults; the remainder of the studies exclusively evaluated children. Two randomized controlled trials found that office-based vergence and accommodative therapies were effective in improving motor outcomes in children with symptomatic CI. However, the studies reported conflicting results on the efficacy of office-based therapy for treating symptoms of CI. Data were inconclusive regarding the effectiveness of home-based therapies (including pencil push-ups and home computer therapy) compared with home placebo. In young adults, office-based vergence and accommodative therapies were not superior to placebo in relieving symptoms of CI. CONCLUSIONS: Level I evidence suggests that office-based vergence and accommodative therapies improve motor outcomes in children with symptomatic CI, although data are inconsistent regarding symptomatic relief. Evidence is insufficient to determine whether home-based therapies are effective.
Assuntos
Acomodação Ocular/fisiologia , Movimentos Oculares/fisiologia , Transtornos da Motilidade Ocular/terapia , Oftalmologia/organização & administração , Ortóptica/métodos , Avaliação da Tecnologia Biomédica , Academias e Institutos/organização & administração , Adolescente , Adulto , Criança , Serviços de Assistência Domiciliar , Humanos , Transtornos da Motilidade Ocular/diagnóstico , Transtornos da Motilidade Ocular/fisiopatologia , Cooperação do Paciente , Satisfação do Paciente , Consultórios Médicos , Estados Unidos , Visão Binocular/fisiologia , Adulto JovemRESUMO
An analysis is presented of actions taken by the Brazilian research institution Fiocruz for the communication and popularization of science, from two perspectives. The aim was to investigate how a system for the communication and popularization of science is organized at a large scientific institution and how it is articulated with the institutional discourse. A brief review is presented of how the topic has developed over the history of Fiocruz, followed by a discussion of the way it has been addressed in its official planning documents. The science communication/popularization actions undertaken in 2015 and 2016 were mapped out and classified according to how they interact with the public, giving a better understanding of this area.
Neste trabalho apresentamos uma análise das ações de divulgação e popularização da ciência na Fiocruz a partir de duas perspectivas. O estudo tem por objetivo investigar como se organiza um sistema de divulgação e popularização da ciência em uma instituição científica de grande porte e como esse sistema se articula com seu discurso institucional. Além de fazer uma breve revisão da evolução do tema na história da Fiocruz, realizamos um levantamento de como o mesmo tem sido tratado nos documentos oficiais de planejamento. Com o mapeamento das ações realizadas em 2015 e 2016, foi possível compreender melhor esse universo e classificá-lo de acordo com suas características junto ao público.
Assuntos
Academias e Institutos/história , Ciência/história , Academias e Institutos/organização & administração , Brasil , Fundações/história , História do Século XX , História do Século XXI , Ciência/educaçãoAssuntos
Certificação/normas , Diversidade Cultural , Assistência à Saúde Culturalmente Competente/normas , Dermatologia/normas , Pigmentação da Pele , Academias e Institutos/organização & administração , Academias e Institutos/normas , Atitude do Pessoal de Saúde , Assistência à Saúde Culturalmente Competente/organização & administração , Dermatologia/educação , Dermatologia/organização & administração , Humanos , Dermatopatias/diagnóstico , Dermatopatias/terapia , Estados UnidosRESUMO
Resumo Neste trabalho apresentamos uma análise das ações de divulgação e popularização da ciência na Fiocruz a partir de duas perspectivas. O estudo tem por objetivo investigar como se organiza um sistema de divulgação e popularização da ciência em uma instituição científica de grande porte e como esse sistema se articula com seu discurso institucional. Além de fazer uma breve revisão da evolução do tema na história da Fiocruz, realizamos um levantamento de como o mesmo tem sido tratado nos documentos oficiais de planejamento. Com o mapeamento das ações realizadas em 2015 e 2016, foi possível compreender melhor esse universo e classificá-lo de acordo com suas características junto ao público.
Abstract An analysis is presented of actions taken by the Brazilian research institution Fiocruz for the communication and popularization of science, from two perspectives. The aim was to investigate how a system for the communication and popularization of science is organized at a large scientific institution and how it is articulated with the institutional discourse. A brief review is presented of how the topic has developed over the history of Fiocruz, followed by a discussion of the way it has been addressed in its official planning documents. The science communication/popularization actions undertaken in 2015 and 2016 were mapped out and classified according to how they interact with the public, giving a better understanding of this area.
Assuntos
História do Século XX , História do Século XXI , Ciência/história , Academias e Institutos/história , Ciência/educação , Brasil , Academias e Institutos/organização & administração , Fundações/históriaAssuntos
Academias e Institutos , Indústrias , Colaboração Intersetorial , Neoplasias , Parcerias Público-Privadas , Apoio à Pesquisa como Assunto , Academias e Institutos/economia , Academias e Institutos/organização & administração , Difusão de Inovações , Apoio Financeiro , Humanos , Indústrias/economia , Indústrias/organização & administração , Neoplasias/diagnóstico , Neoplasias/economia , Neoplasias/terapia , Parcerias Público-Privadas/economia , Parcerias Público-Privadas/organização & administração , Apoio à Pesquisa como Assunto/economia , Apoio à Pesquisa como Assunto/organização & administraçãoRESUMO
Umbilical cord blood is an important graft source in the treatment of many genetic, hematologic, and immunologic disorders by hematopoietic stem cell transplantation. Millions of cord blood units have been collected and stored for clinical use since the inception of cord blood banking in 1989. However, the use of cord blood in biomedical research has been limited by access to viable samples. Here, we present a cost-effective, self-sustaining model for the procurement of fresh umbilical cord blood components for research purposes within hospital-affiliated academic institutions.
Assuntos
Pesquisa Biomédica/organização & administração , Bancos de Sangue/organização & administração , Sangue Fetal , Modelos Organizacionais , Academias e Institutos/economia , Academias e Institutos/organização & administração , Academias e Institutos/normas , Pesquisa Biomédica/economia , Pesquisa Biomédica/métodos , Pesquisa Biomédica/normas , Bancos de Sangue/economia , Bancos de Sangue/normas , Coleta de Amostras Sanguíneas/economia , Coleta de Amostras Sanguíneas/métodos , Coleta de Amostras Sanguíneas/normas , California , Análise Custo-Benefício , Feminino , Sangue Fetal/citologia , Sangue Fetal/transplante , Transplante de Células-Tronco Hematopoéticas/economia , Transplante de Células-Tronco Hematopoéticas/métodos , Transplante de Células-Tronco Hematopoéticas/normas , Humanos , Recém-Nascido , GravidezRESUMO
PROBLEM: Medical education academies have been instrumental in providing greater recognition of and promotion for clinician-educators. However, producing education scholarship is essential for clinician-scholar-educator career advancement. Grant funding for education research and protected time to produce scholarship are still lacking for interested physicians, in part due to institutional budget constraints and competing priorities. APPROACH: The Hospital for Special Surgery Academy of Rheumatology Medical Educators was founded in 2011 to promote education scholarship through grants awarded to educators interested in research. Educators were asked to submit proposals aimed at the development of new teaching programs and curricular change. Selected applicants received up to $50,000 per year for one year. Grant money was obtained through directed fundraising from donors. Information from annual grant updates and survey responses from grant recipients in 2017 were used to assess the academy's effectiveness. OUTCOMES: Since 2012, 32 grants have been awarded, totaling $954,045 in funding. Recipients have produced national meeting abstracts, posters, oral presentations, and manuscripts and created unique curricula and electronic learning tools for medical students, residents, fellows, faculty, and patients. Four educators with demonstrated interest and research outcomes were identified during the pilot and received additional funding and support from a dedicated education research assistant. NEXT STEPS: The academy and the innovations grants program highlight the talents of under-supported and under-recognized teaching faculty by allowing them to distinguish themselves academically as clinician-scholar-educators. The success of these educators emphasizes the clear advantages of a formalized structure to achieve the hospital's education goals. Next steps include providing support for a rheumatology fellow to develop an education research career rather than one in bench, clinical, or translational research.
Assuntos
Academias e Institutos/organização & administração , Pesquisa Biomédica/economia , Educação Médica/métodos , Hospitais Especializados/economia , Reumatologia/educação , Pesquisa Biomédica/estatística & dados numéricos , Currículo/estatística & dados numéricos , Bolsas de Estudo/economia , Feminino , Hospitais Especializados/organização & administração , Humanos , Aprendizagem , Masculino , Tutoria/economia , Cidade de Nova Iorque , Médicos/estatística & dados numéricos , Estudantes de Medicina/estatística & dados numéricos , Apoio ao Desenvolvimento de Recursos Humanos/economiaRESUMO
Enormous progress has been made in the field of rheumatology in the past several decades, historically led by publicly funded academic innovators but in more recent times with much greater involvement of the pharmaceutical industry. This shift in resources has created a complex new model for reinvestment in the medical community in which the vast majority of private funds are redirected towards influencing the prescription behaviour of practitioners through 'key opinion leaders', with the main purpose of enhancing and perpetuating profit rather than innovation and critical thinking, and often at the expense of partnerships with scientists (that is, basic and translational researchers) and academic collaborations. This new episteme brings multiple opportunities to rethink approaches to sustaining long-term critical research in the field, ultimately maximizing the return on investment: scientific knowledge for the benefit of patients and society. Central to such strategies should be the rebalancing of academia-industry partnerships towards academic research and the involvement of 'innovation and knowledge leaders', rather than mostly key opinion leaders.
Assuntos
Indústria Farmacêutica/economia , Padrões de Prática Médica/estatística & dados numéricos , Reumatologia/estatística & dados numéricos , Pesquisa Translacional Biomédica/organização & administração , Academias e Institutos/ética , Academias e Institutos/organização & administração , Atitude , Comportamento Cooperativo , Criatividade , Indústria Farmacêutica/organização & administração , Recursos em Saúde/economia , Recursos em Saúde/tendências , Humanos , Investimentos em Saúde/economia , Investimentos em Saúde/ética , Conhecimento , Liderança , Padrões de Prática Médica/tendências , Reumatologia/organização & administração , Pensamento/fisiologia , Pesquisa Translacional Biomédica/métodosAssuntos
Academias e Institutos/organização & administração , COVID-19/epidemiologia , Ortopedia/organização & administração , Pandemias , SARS-CoV-2 , Agendamento de Consultas , Conversão de Leitos , COVID-19/diagnóstico , COVID-19/prevenção & controle , COVID-19/terapia , Gerenciamento Clínico , Procedimentos Cirúrgicos Eletivos , Serviço Hospitalar de Emergência/organização & administração , Necessidades e Demandas de Serviços de Saúde , Unidades Hospitalares/organização & administração , Humanos , Itália , Procedimentos OrtopédicosRESUMO
The NIH-funded Research Centers in Minority Institutions (RCMI) program is currently funding 18 academic institutions to strengthen the research environment and contribution to health disparities research. The purpose of this multiphase mixed-methods study was to establish a uniform evaluation framework for demonstrating the collective success of this research consortium. Methods included discussions of aims and logic models at the RCMI Evaluators' Workshop, a literature review to inform an evaluation conceptual framework, and a case study survey to obtain evaluation-related information and metrics. Ten RCMIs participated in the workshop and 14 submitted responses to the survey. The resultant RCMI Evaluation Conceptual Model presents a practical ongoing approach to document RCMIs' impacts on health disparities. Survey results identified 37 common metrics under four primary categories. Evaluation challenges were issues related to limited human resources, data collection, decision-making, defining metrics, cost-sharing, and revenue-generation. There is a need for further collaborative efforts across RCMI sites to engage program leadership and community stakeholders in addressing the identified evaluation challenges and measurement. Program leadership should be engaged to apply the Evaluation Conceptual Framework and common metrics to allow for valid inter-institutional comparisons and consortium-wide evaluations. Stakeholders could ensure evaluation metrics are used to facilitate community impacts.
Assuntos
Academias e Institutos , Estudos de Avaliação como Assunto , Grupos Minoritários , Universidades , Academias e Institutos/organização & administração , Academias e Institutos/normas , Benchmarking , Humanos , Liderança , Universidades/organização & administração , Universidades/normas , Universidades/estatística & dados numéricosAssuntos
Academias e Institutos/legislação & jurisprudência , Academias e Institutos/organização & administração , Medicina Regenerativa/economia , Medicina Regenerativa/legislação & jurisprudência , Governo Estadual , Pesquisa com Células-Tronco/economia , Pesquisa com Células-Tronco/legislação & jurisprudência , Academias e Institutos/economia , Academias e Institutos/ética , California , Conflito de Interesses , Organização do Financiamento/ética , Humanos , Defesa do Paciente , Medicina Regenerativa/tendênciasRESUMO
BACKGROUND: The Institute for Clinical and Economic Review (ICER) has gained recognition for performing independent health technology assessments (HTAs) that include the cost-effectiveness of selected new technologies in the United States. ICER has similarities with the National Institute for Health and Care Excellence (NICE) in England and Wales, but the amount of overlap and new methods adopted to meet stakeholder needs in the complex U.S. health care system have not been fully analyzed. OBJECTIVE: To perform a comprehensive comparison of ICER and NICE. METHODS: We compared ICER and NICE using the same framework as Drummond et al. (2008), which suggests 4 dimensions for comparison of HTA organizations: structure of HTA programs, methods of HTA, processes for conduct of HTA, and use of HTAs in decision making. RESULTS: We found differences between ICER and NICE in the structure of HTA programs (setup of the organizations, governance issues, and funding); methods (perspective, costs, utilities, discounting, and thresholds); process (relationship with relevant stakeholders, deliberative decision-making processes, and timelines); and the use of HTA in decision making (the format and type of evidence generated, how the evidence is considered, and the format of the recommendations). CONCLUSIONS: ICER uses a different approach for clinical review but performs cost-effectiveness analysis using methods similar to NICE. The key differences between NICE and ICER arise because of important differences between the United Kingdom's "single payer" health care system and the United States's pluralistic system. ICER's lack of mandatory power translates to substantial differences in terms of its processes and type of recommendations. DISCLOSURES: No outside funding supported this study. Thokala has received grants from the Institute for Clinical and Economic Review (ICER) for modeling projects. Carlson has received grants from ICER, unrelated to this study. Drummond has nothing to disclose.
Assuntos
Tecnologia Biomédica/economia , Tomada de Decisões , Avaliação da Tecnologia Biomédica/organização & administração , Academias e Institutos/organização & administração , Análise Custo-Benefício , Inglaterra , Humanos , Estados Unidos , País de GalesAssuntos
Academias e Institutos/organização & administração , Reforma dos Serviços de Saúde/legislação & jurisprudência , Medicina/organização & administração , Docentes/legislação & jurisprudência , Humanos , Itália/epidemiologia , Medicina/estatística & dados numéricos , Seleção de Pessoal/estatística & dados numéricos , PolíticaRESUMO
PURPOSE: To determine the efficacy and safety of sentinel lymph node biopsy (SLNB) in the management of eyelid and conjunctival malignancy. METHODS: A literature search was performed in August 2019 and January 2020 for articles published in English in the PubMed and Cochrane Library databases. This search yielded 151 articles that were reviewed for relevancy, of which 27 were deemed to have met the inclusion criteria for this assessment. The data from these articles were abstracted and the articles were rated for strength of evidence by the panel methodologist. RESULTS: All 27 studies were rated level III, and a total of 197 SLNBs were reported. Diagnoses included conjunctival and eyelid cutaneous melanoma (85 and 42 patients, respectively), sebaceous gland carcinoma (35 patients), squamous cell carcinoma (26 patients), Merkel cell carcinoma (6 patients), pigmented epithelioid melanocytoid tumor (1 patient), mucoepidermoid carcinoma (1 patient), and signet ring carcinoma (1 patient). Tracer was found in regional lymph nodes in 100% of patients in 21 of 27 articles and in 191 of 197 patients overall. The number of lymph nodes removed ranged from 1 to 16, with most ranging from 1 to 5. Tumor-positive lymph nodes were found in 33 of 197 patients (16.8%), prompting recommendations for adjuvant treatments. Survival data were reported for 16 of these patients, with follow-up periods ranging from 3 to 36 months (average, 12.7 months). Fourteen of 16 patients received adjuvant treatments. Nine were alive and well, 1 was alive with metastases, and 6 had died of metastatic disease (including 2 patients who declined additional treatment). False-negative SLNB results were reported in 5 articles involving 9 of 197 procedures (4.6%). Complications were documented in 7 of 27 articles and included transient facial nerve weakness, persistent blue dye staining of the conjunctiva, neck hematoma, and suture abscess. CONCLUSIONS: Sentinel lymph node biopsy is a promising procedure in patients with eyelid and conjunctival malignancy, and it is useful in identifying sentinel lymph nodes. However, at present, insufficient evidence exists showing that SLNB improves patient outcomes and survival. Recognition of microscopic metastatic disease may prove beneficial in staging and guiding adjuvant therapy.